User profiles for Sunil V Badve

Sunil V. Badve

Professor, UNSW Medicine
Verified email at unsw.edu.au
Cited by 6719

[HTML][HTML] Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

…, JA Olson Jr, T Lively, SS Badve… - … England Journal of …, 2018 - Mass Medical Soc
Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …

[HTML][HTML] Prospective validation of a 21-gene expression assay in breast cancer

…, JA Zujewski, T Lively, SS Badve… - … England Journal of …, 2015 - Mass Medical Soc
Background Prior studies with the use of a prospective–retrospective design including
archival tumor samples have shown that gene-expression assays provide clinically useful …

[HTML][HTML] Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 …

…, GW Sledge, JA Sparano, SS Badve - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network …

…, DW Johnson, M Tonelli, MC Rossi, SV Badve… - Bmj, 2021 - bmj.com
Objective To evaluate sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like
peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …

Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis

…, M Ruospo, P Natale, V Saglimbene, SV Badve… - Jama, 2016 - jamanetwork.com
Importance Numerous glucose-lowering drugs are used to treat type 2 diabetes. Objective
To estimate the relative efficacy and safety associated with glucose-lowering drugs including …

[HTML][HTML] Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

…, JA Olson Jr, T Lively, SS Badve… - New England journal …, 2019 - Mass Medical Soc
Background The use of adjuvant chemotherapy in patients with breast cancer may be guided
by clinicopathological factors and a score based on a 21-gene assay to determine the risk …

[HTML][HTML] Effects of allopurinol on the progression of chronic kidney disease

SV Badve, EM Pascoe, A Tiku… - … England Journal of …, 2020 - Mass Medical Soc
Background Elevated serum urate levels are associated with progression of chronic kidney
disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the …

[HTML][HTML] ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and …

A Marx, P Ströbel, SS Badve, L Chalabreysse… - Journal of Thoracic …, 2014 - Elsevier
Introduction: The 2004 version of the World Health Organization classification subdivides
thymic epithelial tumors into A, AB, B1, B2, and B3 (and rare other) thymomas and thymic …

Recent peritonitis associates with mortality among patients treated with peritoneal dialysis

…, A Kemp, P Clayton, W Lim, SV Badve… - Journal of the …, 2012 - journals.lww.com
Peritonitis is a major complication of peritoneal dialysis, but the relationship between peritonitis
and mortality among these patients is not well understood. In this case-crossover study, …

[HTML][HTML] An international study to increase concordance in Ki67 scoring

…, J Bartlett, LM McShane, RA Enos, SS Badve… - Modern …, 2015 - nature.com
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which
has limited its clinical use. Our previous study found variability when laboratories used their …